MELISSA LEE: Open Payments
NPI 1700484524 · SAGINAW, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,531 in 90 payments from 19 companies in 2025. Trend: 2023 $1,651 · 2024 $2,012 · 2025 $1,531
Food & beverage: $1,531
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 46 | $674 |
| PFIZER INC. | 15 | $216 |
| Lilly USA, LLC | 6 | $154 |
| Eisai Inc. | 3 | $61 |
| UCB, Inc. | 3 | $60 |
| Axsome Therapeutics, Inc. | 2 | $50 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $48 |
| Vanda Pharmaceuticals Inc. | 2 | $44 |
| Neurocrine BioSciences, Inc. | 1 | $29 |
| Biogen, Inc. | 1 | $24 |
Products named: QULIPTA, NURTEC ODT, KISUNLA, UBRELVY, BOTOX, Leqembi, Symbravo, HYQVIA.
Industry payments across MI — which companies pay providers there.
